Dopaminergic Dysfunction in Late-Life Depression

NCT04469959 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Late Life Depression
Cognitive Decline
Depressive Disorder, Treatment-Resistant
Levodopa
Gait Impairment

Interventions

DRUG: L-Dopa
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]